Box | Folder		Title
		Series 4: Subject Files, 1931-2000 [series]:
12	1	Indexes: Keysort classifications, [ca. 1990-95]
		Hypertension [H], 1939-96 [subseries]:
		Saluretic Agents [H-1], 1953-91 [subseries]:
12	2-3	Chlorothiazide - Mechanism of action [34.1], 1957-89
12	4	Thiazide - Effects on LVH [34.2], 1982-87
12	5	Thiazide drugs [32], 1958-69, 1984
12	6	Mercurials [31], [after 1985]
12	7	Thiazides' effect on calcium [30], 1990-91
12	8	Aldosterone antagonists [29], 1953-80
12	9	Polythiazide [28], 1961-63
12	10	Non saluretic thiazides [27], 1961-68
12	11	Triamterene and MK870 [26], 1961-85
12	12	Furosemide [25], 1964-79
12	13	Ticrynafen [24], 1978-80
		Blocking Agents [H-2], 1946-96 [subseries]:
12	14	Hexamethonium - Pharmacology [34A], 1950-60
12	15	Hexamethonium - Treatment, Clinical [34B], 1950-56
12	16	Hexamethonium and Hydralazine [34C], 1952-55
12	17	Hexamethonium and Rauwolfia [34D], 1953
12	18	Hexamethonium - Correspondence and reports [34E], 1951-64
12	19	Pentolinium - Pharmacology [33A], 1956-60
12	20	Pentolinium - Clinical [33B], 1953-56
12	21	Pentolinium - with Hydralazine [33C], 1955
12	22	Pentolinium - with Rauwolfia [33D], 1954-55
12	23	Pentolinium - Correspondence and reports [33E], 1954-55
12	24	Chlorisondamine - Pharmacology [32A], 1954-58
12	25	Chlorisondamine - Treatment [32B], 1955-57
12	26	Chlorisondamine - Correspondence and reports [32C], 1954-56
12	27	Mecamylamine [31], 1955-60
12	28	Miscellaneous blocking drugs - Arfonad [30], 1946-61
12	29	Ganglion blocking agents - Trimethidinium methosulfate [30], 1958-62
12	30	Pempidine [30], 1960
12	31-32	Guanethidine [29], 1959-76
12	33	Darenthin (or Bretylium) [28], 1959-62
12	34	Iproniazid and Catron [27], 1959-63
12	35	Pargyline [26], 1961-64
12	36	Ganglion blocking agents - Literature, side effects, toxicity, tolerance [25], 1948-63
12	37	Ganglion blocking agents - General chemical and pharmacological [25], 1947-63
12	38	Ganglion blocking agents - Clinical uses other than in hypertension [25], 1948-56
12	39	Sympatholytic, selective [23], 1960-66
12	40	General [22], 1948-74
12	41	Phentolamine (Regitine) [21], 1965
12	42-43	Adrenergic blockers - Various (includes Labetalol) [19], 1949-85
12	44	Aldomet [18], 1961-88
12	45-47	Beta adrenergic blockers [17], 1966-96
12	48-49	Propranolol [16], 1966-83
12	50	Angiotensin blockers - including Saralasin [15], 1984-95
12	51	Angiotensin blockers - Enalapril 421 or 521 [15A], 1978-90
12	52	Losartan [15B], 1992-95
13	1	Clonidine [14], 1975-85
13	2	Guanabenz [13], 1981-83
13	3	Thiocyanate [12], [after 1970]
13	4	Calcium Channel Block [7], 1995
13		Etiology and Pathogenesis [H-3], 1948-95 [subseries]:
13	5-6	Renin - Renal pressor theory [34], 1959-90
13	7	Kidney in [hypertension] - Pyelonephritis [33], 1959-70
13	8	Unilateral renal vascular disease [32], 1956-87
13	9	Renoprival [31], 1951-65
13	10	Renal, other [30], 1955-86
13	11-12	Salt in hypertension [29], 1955-87
13	13-14	K+ in diet and Na/K+ Ratio. Also, calcium [29A], 1975-88
13	15	Salt sensitivity - Potassium [29B], 1972-95
13	16	Neural [28], 1975-94
13	17	Baroreceptor theories [27], 1948-91
13	18	Sympathetic nerves [26], 1949-83
13	19	Brain and post, pituitary [25], 1958-88
13	20-21	Emotional stress - Neurogenic, other [ 24], 1950-86
13	22	Adrenal cortex [23], 1949-91
13	23	Hormonal, adrenal medulla [22], 1961-88
13	24	Pituitary in [hypertension] [21], 1948-50
13	25	Hormonal, other [20], 1955-82
13	26	Coarctation of aorta [19], 1951-88
13	27	Hypertension and heredity [18], 1953-87
13	28	Environment [17], 1957-77
13	29	Ca, Mg [16], 1985
13	30-31	Other ions than Na+ - Mg++, Ca++, K+, Cl [15], 1961-94
13	32-33	Fluid volumes in [hypertension] [14], 1952-93
13	34-38	Epidemiological studies [13], 1953-91
13	39-40	Epidemiology - Racial differences [13A], 1956-75
13	41	Exaggerated natriuresis in [hypertension] [12], 1949-62
13	42	Toxemia of pregnancy [11], 1964-84
13	43	Cardiogenic [10], 1962-84
14	1	Miscellaneous [9], 1962-87
14	2	History of hypertension [8] [photograph], [ca. 1960-64]
14	3	Reviews, general [7], 1976-80
14	4	Kallikrein and prostaglandins [6], 1968-85
14	5	Fast-twitch muscle fibers in hypertension - lower body compression [5], 1979-84
14	6	Atrial natriuretic factor [4], 1984-90
14	7	Insulin resistance diabetes [3], 1986-91
14	8	Obesity [3 - crossed out in index], 1987
14	9	Endothelium relaxing factor, etc. [2], 1989
		Other Antihypertensive Agents, General Treatment Control Studies [H-4], 1940-96 [subseries]:
14	10	Hydralazine - Literature - Clinical [34], 1951-83
14	11	Hydralazine - Literature - Pharmacology [34], 1951-81
14	12	Hydralazine - Literature - Toxicity [34], 1953-82
14	13	Hydralazine - like agents [33], 1945-49
14	14	Rauwolfia - Side effects [32], 1954-83
14	15	Rauwolfia - Crude root [31], 1955-63
14	16	Reserpine - Pharmacology [29], 1954-77
14	17	Reserpine - Antiarrhythmic activity [29], 1955-66
14	18-19	Rauwolfia - Reserpine - Treatment [29], 1954-84
14	20	Rauwolfia - Various alkaloids [28], 1955-65
14	21	Veratrum - Pharmacology [27], 1949-66, 1983
14	22	Veratrum - Viride - Clinical treatment [26], 1948-54
14	23	Control studies [25], 1960-79, 1996
14	24	Veratrum - Other alkaloids - Protoveratrine, etc., Viscum album [24], 1949-59
14	25	Veratrum - Neogermitrine assay data [24], 1950
14	26	Sympathectomy [21], 1940-61
14	27	Miscellaneous [20], 1948-69
14	28	Azide Sodium - Literature [20], 1954-61
14	29	Hypertensive agent IN-66 (Irwin, Neisler and Co.) [20] [Restricted], 1952-1953
14	30	Adrenalectomy [19], 1951-54
14	31-34	Treatment Dietary [18], 1948-57, 1973-91
14	35	Surgery of renal hypertension [17], 1963
14	36	Renal transplants [16], 1964-65
14	37	Diazoxide [15], 1976
14	38	General discussion and review [14], 1974-81
14	39-40	Prazosin [13], 1974-95
14	41	Minoxidil [12], 1973-81
14	42	Cost of drugs [11], 1978-83
14	43-46	FDA and drug regulations [10], 1971-83
15	1	Psychophysiological techniques [9], 1972-84
15	2	National programs [8], 1977-82
15	3	Calcium antagonists - General [7A], 1977-92
15	4	Calcium antagonists - Nitrendipine [7C], [1984-85]
15	5	Calcium antagonists - Diltiazem [7D], 1982-89
15	6	Verapramil [7E], 1982-87
15	7	Exercise [6], 1978-86
15	8	Reverse titration [5], 1967-82
15	9	Serotonin antagonists [4], 1984-86
		Clinical [H-5], 1943-93 [subseries]:
15	10	General discussion of disease - Reviews [34], 1946-50, 1970
15	11	Subarachnoid hemorrhage [33], 1982
15	12	Left Ventricular Hypertrophy / ECG or VCG in Hypertension [32], 1962-97
15	13	Prognosis, untreated [31], 1943-74
15	14	Treatment effect on prognosis - Indications for Rx mild [30], 1956-88
15	15	Prognosis with surgical [29], 1950-62
15	16	Reactivity in borderline hypertension [28], 1955-90
15	17	Practical details of drug treatment, home BPs, cost, etc. [27], 1974-88
15	18	Antihypertensive Drugs - Treatment, general [26], 1959-93
15	19	Systolic hypertension [25], 1982-88
15	20	Effects of Rx on organic damage (Cardiac, renal) [24] [photograph], 1951-91
15	21-22	Blood pressure recording [23], 1954-90
15	23	Blood pressure - Casual versus basal [22], 1953-89
15	24	Ambulatory BP monitoring [22A], 1981-90
15	25	Miscellaneous symptoms (Headache, etc.) [21], 1962, 1986-88
15	26	Uric acid, gout, gouty nephritis [20], 1963, 1966
15	27	Hypertensive encephalopathy and crisis [19], 1975-92
15	28	Dissecting aneurysm [18], 1968-82
15	29-30	Clinics for hypertension - Detection, costs [17], 1972-98
15	31	Hypertension in children [16], 1960-88
15	32	Physician education - Tests, nurse education, etc. [15], 1959-79
15	33	Hypertension in the aged [14], 1970-92
15	34-35	Obesity - Weight reduction [13], 1967-92
15	36	Comments on trials [12A], 1974-90
15	37-38	Compliance [11], 1967-87
15	39	Blacks and other race [10], 1976-89
15	40	Low lipid diets [9], 1981-87
15	41	Mental and behavioral [with and without] Rx [8], 1971-89
15	42	Stepdown of Rx [7], 1956, 1975-89
15	43	Left Ventricular Hypertrophy [6], 1979-94
15	44	The J curve [5], 1985-91
15	45	Circadian rhythm [4], 1992
15	46	Kidney in hypertension [3], 1988-92
15	47	Diabetes and HBP - Nephropathy [2], 1989-93
		Atherosclerosis [H-6], 1949-93 [subseries]:
15	48	Atherosclerosis - Cholesterol in [34], 1957-89
15	49	Atherosclerosis and L[ow]-D[ensity] L[ipoproteins] [33], 1982
15	50	Atherosclerosis and dietary fat [32], 1955-90
15	51	Physical activity [31], 1960, 1981-87
15	52	Coronary [30], 1963-82
16	1	Lipids other than cholesterol [29], 1949-59, 1982
16	2	MER 29 - Cholesterol synthesis antagonists [28], 1960-62
16	3	Thyroid substances [27], 1949-57
16	4	Vessel wall factors [26], 1958-93
16	5-6	Miscellaneous drug treatment [25], 1957-91
16	7	Reviews [24], 1976-89
16	8-10	Epidemiology of coronary artery disease [23] [photographs], [1967]-88
16	11	By-pass surgery [22], 1977-90
16	12	Apolipoproteins [21], 1986
16	13	Blood clotting factors and prevention of M[yocardial] I[nfarction] [21], 1980-82
16	14	H[igh]-D[ensity] L[ipoprotein] [20], 1980-91
16	15	C[oronary] H[eart] D[isease] mortality - secondary prevention trials [19], 1984
16	16	Exercise [18], 1982-84
16	17	Acute Miyocardial] I[nfarction] [17], 1988-91
16	18	Hypertension and accelerated atherosclerosis [16] [photograph], 1960-82
16	19	Primary prevention control trials [15], 1984-91
16	20	Treatment of coronary occlusion with anticoagulants [14], 1985-90
16	21	Angina [13], 1984
16	22	Smoking [11], 1991
		Organ Systems In and Types of Hypertension [H-7], 1939-89 [subseries]:
16	23	Malignant - Untreated [34], 1939, 1948-79
16	24	Malignant - Treated [33] [photographs], 1953-67
16	25	General [32], 1961
16	26	Kidney in [31], 1941-78
16	27	Heart in [30], 1958-89
16	28-29	Brain in [29], 1945-88
16	30	Large vessels in [28], 1955-88
16	31-32	Small vessels in [27], 1956-89
16	33	Other organs in [26], 1952-60
16	34-35	Pheochromocytoma [25], 1954-85
16	36	Fundi [24], 1962, 1980-85
16	37	Adrenal cortex in [23], 1941-75
16	38	Atherosclerosis in [22], 1959-87
16	39	Classification [21], 1946-58
16	40	S[pontaneously] H[ypertensive] R[at] [20], 1956-81
16	41	Veins - Venous tone [19], 1978-87
16	42	Vascular endothelium [18], [ca. 1980-89]
		Hemodynamics [T], 1941-91 [subseries]:
		Heart [T-1], 1948-91 [subseries]:
16	43	Theoretical concepts - New method [34.1], 1963
16	44-45	Output [33], 1948-63, 1977-84
16	46	Flow [32], 1949-62
16	47	Pressure [31], 1948-64
16	48	Velocity [30], 1962, 1980
16	49	Volume [29], 1955-64, 1991
16	50	Resistance [27], 1963, 1979
16	51	Work [26], 1963
16	52	O2 Consumption [24], 1965
16	53	Metabolism plus pH plus myogenic response [23], 1962
16	54	Electrical phenomena [21], 1959
16	55	Methods - Clearance or Fick [20], 1953
16	56	Methods - Radioisotopic tracers [18], 1980
16	57	Methods - Volume dilution [17], 1954-63
16	58	Methods - Electrocardiography [16], 1959
16	59	Methods - Colorimetric [14], 1961
16	60	Blood oxygen and CO2 [13], 1963
16	61	Elasticity of vessels [12], 1955-62
16	62	Pulse wave contours [10], 1961-62
16	63	Methods - Miscellaneous [8], 1961
		Small Vessels [T-2], 1941-87 [subseries]:
17	1	Flow [32], 1955-87
17	2	Pressure [31], 1941, 1956
17	3	Volume [29], 1960-64
17	4	Resistance [27], 1960-65
17	5	Anatomical studies [22], 1957
17	6	Methods - Plethysmographic, or other physical [19], 1959-62
17	7	Methods - Radioisotopic tracers [18], 1963
17	8	Nervous control [13], 1963-68
17	9	Electrolytes in relation to [small vessels] [11], 1960
		Brain [T-3], 1960-61 [subseries]:
17	10	Flow [32], 1960-61
		Kidney [T-4], 1951-82 [subseries]:
17	11	Flow [32], 1951-82
17	12	Volume [29], 1956-58
17	13	Temperature [28], 1962
17	14	Methods - Radioisotopic tracers [18], 1956-60
		Splanchnic Minus Renal [T-5], 1949-63 [subseries]:
17	15	Flow [32], 1949-63
17	16	Pressure [31], 1959-63
17	17	Resistance [27], 1962
		Coronary Vessels [T-6], 1959-65 [subseries]:
17	18	Flow [32], 1964-65
17	19	Methods - Radioisotopic disease [18], 1961-64
17	20	Methods - X-Ray [15], 1959-62
		Venous System [T-7], 1952-64 [subseries]:
17	21	Flow [32], 1959
17	22	Pressure [31], 1952-55
17	23	Volume [29], 1955-64
17	24	Resistance [27], 1962
17	25	Methods - Plethysmographic, or other physical [19], 1957
		Extremity - Total Limb or 9 plus 10 [T-8], 1959 [subseries]:
17	26	Methods - Plethysmographic, or other physical [19], 1959
		Extremity - Skin or Digit [T-9], 1960-74 [subseries]:
17	27	Theoretical concepts [34], 1968
17	28	Flow [32], 1962-64
17	29	Methods - Plethysmographic, or other physical [19], 1960
17	30	Electrolytes in Relation To [11], 1974
		Extremity - Muscle or Limb Segment [T-10], 1958-89 [subseries]:
17	31	Flow [32], 1958-59, 1988-89
		Multiple Organs [T-11], 1952-63 [subseries]:
17	32	Flow [32], 1961-63
17	33	Volume [29], 1952, 1961
		Aorta and/or Large Arteries [T-13], 1957-73 [subseries]:
17	34	Flow [32], 1959-69
17	35	Pressure [31], 1959-73
17	36	Volume [30], 1962-64
17	37	Anatomical studies [22], 1957
17	38	Methods - Clearance or Fick [20], 1962
17	39	Methods - Volume dilution [17], 1965
17	40	Methods - X-Ray [15], 1961
17	41	Elasticity of vessels [12], 1960-62
17	42	Electrolytes in relation to [aorta and/or large arteries] [11], 1960
17	43	Methods - Miscellaneous [8], 1960-61
		Pulmonary Circulation [T-14], 1949-65 [subseries]:
17	44	Flow [32], 1954-62
17	45	Pressure [31], 1949-63
17	46	Volume [29], 1960-65
17	47	Resistance [27], 1957
17	48	Elasticity of vessels [12], 1962
		Lymphatics [T-15], 1959 [subseries]:
17	49	Pressure [31], 1959
		Miscellaneous [U], 1931-2000 [subseries]:
		Drugs Other than Antihypertensive Agents [U-1], 1942-86 [subseries]:
17	50	Pressor drugs - Epinephrine (Adrenaline) [29], 1957-62
17	51	Pressor drugs - Levarterenol (Norepinephrine) [28], 1953-68
17	52	Pressor drugs - Other sympathomimetic amines [27], 1954-75
17	53	Pressor drugs - Angiotensin [26], 1942, 1957-76
17	54	Pressor drugs - Derived from biological materials [24], 1960
17	55	Cardiac drugs - Digitalis [22], 1948-60
17	56	Cardiac drugs - Quinidine, Pronestyl [21], 1951-60
17	57	Serotonin [14], 1952-59
17	58	Histamine [13], 1969
17	59	Depressor polypeptides (Bradykinin, etc.) [12], 1962-63
17	60	SI Units [11], 1986
		Studies Other than Hemodynamics [U-2], 1952-73 [subseries]:
17	61	Electrocardiograms [29], 1959
17	62	X-Ray [28], 1961
17	63	Extracellular fluid volume [26], 1952-63
17	64	Total body water [25], 1961
17	65	Total exchangeable sodium or potassium [23], 1955-61
17	66	Total blood volume [22], 1955-68
17	67	Muscle contraction, metabolism, cardiac contraction [21], 1962-63
17	68	Heart sounds and murmurs [20], 1955
17	69	Myogenic response [19], 1959-64
17	70	Electrokymography [18], 1962
17	71	Systolic time intervals [17], 1973
		Neural Control of Circulation [U-3], 1959-82 [subseries]:
17	72	Catecholamine metabolism [15], 1963-82
17	73	Pineal, including carbolines [14], 1962
17	74	Reflexes with afferents from heart and lung [13], 1959-75
17	75	Sympathetic vasodilator nerves [10], 1961
17	76	Sympathetic vasoconstrictor nerves [9], 1959-60
17	77	General or integrated [8], 1960-63
17	78	Baroreceptors [5], 1961-63, 1978
17	79	Hypothalamus [1], 1959-61
		Hemodynamic Techniques [U-4], 1949-87 [subseries]:
17	80	Blood Flow - Sonic [29], 1962
17	81	Blood Flow - Thermistor [28], 1949-71
17	82	Blood Flow - Electromagnetic [27], 1952-66
17	83	Blood Flow - Radiopotassium technique and similar [26], 1961-68
17	84	Blood Flow - Other special [25], 1950-61
17	85	Cardiac diameter mercury strain gauge [24], 1953
17	86	Cardiac "force" strain gauge [22], 1950-57
17	87	Blood viscosity [20], 1960-61
17	88	Electrical conductivity [19], 1959-61
17	89	Aortic or other large artery diameter - Methods other than x-ray [18], 1961
17	90	Limb Plethysmography - Strain gauge [17], 1964, 1980-84
17	91	Cardiac output by aortic pulse contour or differential pressure [16], 1949-65
17	92	Cardiac output by dye method [15], 1957-65, 1987
17	93	Blood pressure - Methods for measurement in man [14], 1959-86
17	94	Blood pressure - Methods for measurement in animals [13], 1957-66
17	95	Heart pumps [12], 1960-62
17	96	Renograms [11], 1963-71
17	97	Pulse wave velocity and contour [10], 1964
17	98	Microjuncture techniques [9], 1966
17	99	General animal technique (such as anesthesia, etc.) [8], 1963
17	100	Special animal techniques - Miscellaneous [7], 1963
17	101	Chronic implantation and catheterization technique [6], 1963
17	102	Echocardiography [5], 1971-74
		Environmental Factors [U-5], 1955-75 [subseries]:
17	103	Cold [28], 1955-62
17	104	Exercise [24], 1975
17	105	Hemodynamics - Postural hypotension [22], 1959-62
17	106	Dissecting aneurysm [11], 1966
		Effects of Changes Imposed on the Organism [U-6], 1940-81 [subseries]:
17	107	Exercise [29], 1954-59
17	108	Posture and postural hypertension [22], 1940-81
17	109	Smoking [21], 1959
17	110	Fever [20], 1959
17	111	Diving [19], 1962
17	112	Experimental ventricular pre-excitation [18], 1964
		Diseases States [U-7], 1945-83 [subseries]:
17	113-114	Cardiac failure [29], 1951-83
17	115	Myocardial infarction [28], 1954-76
17	116	Valvular heart disease [27], 1955-59
17	117	Congenital heart disease [26], 1955-64
17	118	Other heart disease [25], 1955
17	119	Pulmonary embolism and infarction [24], 1965
17	120	Peripheral vascular diseases - Arterial [22], 1955-62
17	121	Peripheral vascular diseases - Venous [21], 1955
18	1	Shock [19], 1945-64
18	2	Nephritis, glomerulo and pyelo [17], 1959
18	3	Other renal disorders [16], [1962]
18	4	Cerebrovascular disorders [14], [1963]
18	5	Arteriovenous fistula [12], 1960-62
18	6	Cardiac resuscitation [11], 1962-64
18		Computers and General [U-8], 1953-83 [subseries]:
18	7	Use as methodology aid [25], 1962
18	8	Diagnostic aid - general [24], 1962
18	9	Diagnostic aid - ECG [23], 1959-61, 1983
18	10	Hydrodynamics, hydraulics [14], 1953-58
18		Transmembrane Exchange [U-9], 1955-85 [subseries]:
18	11	Transcapillary exchange - Large molecules [29], 1960-63, 1984-85
18	12	Transcapillary exchange - Na[+ ]and K[+] [27], 1957-61
18	13	Transcapillary exchange - Water [26], 1962
18	14	Cellular membrane exchange - Na[+] and K[+] [24], 1955-62
18	15	Cellular membrane exchange - Water [23], 1959
18	16	Cellular membrane exchange - Other molecules [22], 1962
18		Cooperative Studies and Medical Statistics [U-10], 1960-85 [subseries]:
18	17	Methodology of cooperative studies [29], 1961-85
18	18-19	Double blind control studies in hypertension [28], 1960-77
18	20	Medical statistics - General [27], 1961-82
18	21	Medical research [26], 1964-76
18	22	Use of animals in research [25], [after 1952]
18	23	Medical ethics [24], 1966
18		[Subjects Not Filed by Freis], 1931-2000 [subseries]:
18	24	[Antihypertensive agents], 1947-56, 1977-92
18	25	[Antihypertensive therapy and side effects], 1950, 1973-95
18	26	Apex cardiogram etc., 1959-73
18	27	Arterial distensibility in normotensive and hypertensive patients, 1962-76, 1984
18	28	Arterial elasticity, 1959-65, 1978-87
18	29-30	Arterial pulse contours - literature, 1931, 1956-68
21	2	Arterial pulse contours - literature, 1965
18	31	Arterial wall characteristics [photographs], 1954-71
18	32	Arteriosonde for assessing "basal" BP, 1956, 1976-77
18	33	[Blood flow], 1949, 1976
18	34	Cards, 1968-70
21	3-4	Chronic Bright's Disease, 1974
18	35	Circadian rhythm study, 1988-89
18	36	[Congestive heart failure], 1953-91
18	37	Conjunctival blood vessels, 1983-86
18	38-39	Diuretic hypokalemia, 1963-94
18	40	Ejection period [photograph], 1964-77
18	41	Fixed dose combinations Rx, 1998
18	42	Heart sounds, 1958-72
18	43	[Hexamethonium], 1950-51
18	44	[High blood pressure], 1959-87
18	45	Isovolumic contraction time, 1959-76
18	46	[Kidneys], 1955-58
18	47	KCG [Kinetocardiogram] [photograph], 1959-76
18	48-49	[Leukocytes], 1959-84
18	50	New projects, 1950, 1979-89
18	51	PRA response to HCTZ and BP responsiveness correlation, 1983-90
18	52	[Propranolol], 1969-73
18	53-54	Pulse wave studies, 1955-89
18	55-56	Pulse wave velocity, 1945, 1960-71, 1989-2000
18	57	Rabbit Athero, 1955-64
18	58	Salt volume and prevention of hypertension, 1953-54, 1976-93
19	1	Sodium in WBC in hypertension and after antihypertensive drugs, 1959-76
19	2	Step down, 1975-89
19	3-5	Thiazides - Hypokalemia, 1962-93
19	6	Thiazides - Other side effects, 1991
19	7	Thoughts - Ideas, 1959-60, 1976-82
19	8	Transcapillary exchange in hypertension, 1963-80